Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Young

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Antiviral Therapy|February 20, 2010
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapyHeiner C Bucher, Martin Rickenbach, Jim Young, et al.
Journal of Patient Safety|August 15, 2014
Organizational, Cultural, and Psychological Determinants of Smart Infusion Pump Work Arounds: A Study of 3 U.S. Health SystemsBenjamin B Dunford, Matthew Perrigino, Sharon J Tucker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 2, 2015
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJim Young, Yongling Xiao, Erica E M Moodie, et al.
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|September 30, 2006
Nonadherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipientsKris Denhaerynck, Ariane Desmyttere, Fabienne Dobbels, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 10, 2026
The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort studyJim Young, Shouao Wang, Matthew Knight, et al.
BMC Infectious Diseases|January 8, 2017
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver diseaseJim Young, Nina Weis, Harald Hofer, et al.
Journal of the International AIDS Society|November 9, 2017
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in CanadaSahar Saeed, Erin C Strumpf, Erica Em Moodie, et al.
Medicine|January 13, 2017
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretroviralsMohaned Shilaih, Alex Marzel, Dominique L Braun, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Antiviral Therapy|February 20, 2010
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapyHeiner C Bucher, Martin Rickenbach, Jim Young, et al.
Journal of Patient Safety|August 15, 2014
Organizational, Cultural, and Psychological Determinants of Smart Infusion Pump Work Arounds: A Study of 3 U.S. Health SystemsBenjamin B Dunford, Matthew Perrigino, Sharon J Tucker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 2, 2015
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJim Young, Yongling Xiao, Erica E M Moodie, et al.
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|September 30, 2006
Nonadherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipientsKris Denhaerynck, Ariane Desmyttere, Fabienne Dobbels, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 10, 2026
The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort studyJim Young, Shouao Wang, Matthew Knight, et al.
BMC Infectious Diseases|January 8, 2017
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver diseaseJim Young, Nina Weis, Harald Hofer, et al.
Journal of the International AIDS Society|November 9, 2017
Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in CanadaSahar Saeed, Erin C Strumpf, Erica Em Moodie, et al.
Medicine|January 13, 2017
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretroviralsMohaned Shilaih, Alex Marzel, Dominique L Braun, et al.
Pharmacoepidemiology and Drug Safety|November 3, 2021
Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the North American AIDS Cohort Collaboration on Research and DesignJim Young, Vincent Lo Re, H Nina Kim, et al.
Pageof 8